285 related articles for article (PubMed ID: 11150348)
1. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists.
Ralph RJ; Paulus MP; Fumagalli F; Caron MG; Geyer MA
J Neurosci; 2001 Jan; 21(1):305-13. PubMed ID: 11150348
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
[TBL] [Abstract][Full Text] [Related]
3. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.
Ralph-Williams RJ; Paulus MP; Zhuang X; Hen R; Geyer MA
Biol Psychiatry; 2003 Feb; 53(4):352-9. PubMed ID: 12586455
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice.
Ralph-Williams RJ; Lehmann-Masten V; Otero-Corchon V; Low MJ; Geyer MA
J Neurosci; 2002 Nov; 22(21):9604-11. PubMed ID: 12417685
[TBL] [Abstract][Full Text] [Related]
5. Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice.
Doherty JM; Masten VL; Powell SB; Ralph RJ; Klamer D; Low MJ; Geyer MA
Neuropsychopharmacology; 2008 Oct; 33(11):2648-56. PubMed ID: 18075489
[TBL] [Abstract][Full Text] [Related]
6. Dorsal striatum D1-expressing neurons are involved with sensorimotor gating on prepulse inhibition test.
Rodrigues S; Salum C; Ferreira TL
J Psychopharmacol; 2017 Apr; 31(4):505-513. PubMed ID: 28114835
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic drug-induced locomotor hyperactivity and prepulse inhibition regulation in male and female aromatase knockout (ArKO) mice: role of dopamine D1 and D2 receptors and dopamine transporters.
Chavez C; Gogos A; Jones ME; van den Buuse M
Psychopharmacology (Berl); 2009 Oct; 206(2):267-79. PubMed ID: 19597801
[TBL] [Abstract][Full Text] [Related]
8. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.
Wakabayashi C; Numakawa T; Ooshima Y; Hattori K; Kunugi H
Psychopharmacology (Berl); 2015 Dec; 232(24):4393-400. PubMed ID: 26359228
[TBL] [Abstract][Full Text] [Related]
9. Role of amygdala dopamine D1 and D2 receptors in the acquisition and expression of fructose-conditioned flavor preferences in rats.
Bernal S; Miner P; Abayev Y; Kandova E; Gerges M; Touzani K; Sclafani A; Bodnar RJ
Behav Brain Res; 2009 Dec; 205(1):183-90. PubMed ID: 19573566
[TBL] [Abstract][Full Text] [Related]
10. The role of dopamine receptors in regulating the size of axonal arbors.
Parish CL; Finkelstein DI; Drago J; Borrelli E; Horne MK
J Neurosci; 2001 Jul; 21(14):5147-57. PubMed ID: 11438590
[TBL] [Abstract][Full Text] [Related]
11. The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice.
Quintero GC; Spano D; Lahoste GJ; Harrison LM
Neuroreport; 2008 Oct; 19(16):1563-6. PubMed ID: 18845937
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.
Gresack JE; Seymour PA; Schmidt CJ; Risbrough VB
Psychopharmacology (Berl); 2014 May; 231(10):2189-97. PubMed ID: 24363077
[TBL] [Abstract][Full Text] [Related]
13. Reduced startle gating after D1 blockade: effects of concurrent D2 blockade.
Swerdlow NR; Shoemaker JM; Bongiovanni MJ; Neary AC; Tochen LS; Saint Marie RL
Pharmacol Biochem Behav; 2005 Oct; 82(2):293-9. PubMed ID: 16188305
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopamine receptor plasticity in neurotensin deficient mice.
Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor antagonists block nerve growth factor-induced hyperactivity.
Kobayashi S; Ogren SO; Ebendal T; Olson L
Eur J Pharmacol; 1997 May; 326(1):1-5. PubMed ID: 9178648
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
[TBL] [Abstract][Full Text] [Related]
17. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
Mohd-Yusof A; Veliz A; Rudberg KN; Stone MJ; Gonzalez AE; McDougall SA
Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612
[TBL] [Abstract][Full Text] [Related]
18. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
Thomas WS; Neal-Beliveau BS; Joyce JN
Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
[TBL] [Abstract][Full Text] [Related]
19. Effects of SCH23390 and raclopride on a run-climb-run behavioral task in rats.
Liao RM; Lin JY; Cheng RK; Liao JJ
Chin J Physiol; 2001 Dec; 44(4):151-60. PubMed ID: 11908544
[TBL] [Abstract][Full Text] [Related]
20. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
Peacock L; Hansen L; Mørkeberg F; Gerlach J
Neuropsychopharmacology; 1999 Jan; 20(1):35-43. PubMed ID: 9885783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
